{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:20:36Z","timestamp":1788337236905,"version":"build-2803163510"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Circulating lipids are widely used in cardiovascular risk assessment, but their relationship with atrial fibrillation (AF) differs from the conventional atherosclerotic framework. Higher triglyceride levels have often been associated with increased AF risk, whereas lower total cholesterol, low-density lipoprotein cholesterol, or remnant cholesterol have paradoxically been linked to greater risk in some populations. These inconsistent findings suggest that lipid measures may reflect stage-specific metabolic and clinical phenotypes rather than uniform causal exposures. This narrative review compares lipid-related evidence across two clinically distinct outcomes: incident AF and recurrence after catheter ablation. We examine conventional lipid measures, apolipoproteins, lipoprotein(a), and composite or longitudinal indices related to insulin resistance and metabolic burden. For incident AF, cholesterol-related markers show inverse, nonlinear, and population-dependent associations, while Mendelian randomization studies have not consistently supported direct causal effects. Post-ablation recurrence represents a treatment-response outcome occurring in patients with an established arrhythmogenic substrate and may be influenced by pre-existing atrial remodeling, lesion formation, postprocedural inflammation and repair, and residual triggers. In this setting, several composite or longitudinal indices integrating glycemia, adiposity, inflammation, or temporal variation have shown more consistent associations than individual conventional lipid measures in some cohorts. However, the evidence remains predominantly observational and is limited by heterogeneity in study populations, ablation modalities, recurrence definitions, rhythm-monitoring strategies, covariate adjustment, and treatment background. Studies of lipid-lowering and cardiometabolic therapies further indicate that changes in lipid concentrations do not necessarily produce parallel changes in AF risk or post-ablation rhythm outcomes. Accordingly, circulating lipids and their derived indices may be better interpreted as stage-specific markers of systemic metabolic burden, inflammatory status, comorbidity, and atrial substrate rather than as isolated causal factors or direct therapeutic targets. Future studies should prioritize longitudinal assessment, standardized outcome surveillance, external validation of incremental predictive value, and evaluation of treatment response before these measures can be incorporated into AF risk stratification or post-ablation management.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1909014","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:58:09Z","timestamp":1788335889000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating lipid profiles and atrial fibrillation: from incident risk to post-ablation recurrence"],"prefix":"10.3389","volume":"13","author":[{"given":"Mi","family":"Yan","sequence":"first","affiliation":[{"name":"Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jjcc.2024.05.007","article-title":"Atrial structural remodeling and atrial fibrillation substrate: a histopathological perspective","volume":"85","author":"Yamaguchi","year":"2025","journal-title":"J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacl.2019.12.002","article-title":"Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"14","author":"Guan","year":"2020","journal-title":"J Clin Lipidol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/clc.23430","article-title":"Lipid levels and risk of new-onset atrial fibrillation: a systematic review and dose-response meta-analysis","volume":"43","author":"Yao","year":"2020","journal-title":"Clin Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e012771","DOI":"10.1161\/JAHA.119.012771","article-title":"Low lipid levels and high variability are associated with the risk of new-onset atrial fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12997\/jla.2023.12.1.73","article-title":"Evaluation of the paradoxical association between lipid levels and incident atrial fibrillation according to statin usage: a nationwide cohort study","volume":"12","author":"Ahn","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.hrthm.2024.05.044","article-title":"Low remnant cholesterol and the subsequent risk of new-onset atrial fibrillation: a prospective cohort study","volume":"21","author":"Chen","year":"2024","journal-title":"Heart Rhythm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e033840","DOI":"10.1161\/JAHA.123.033840","article-title":"Association between remnant cholesterol and risk of incident atrial fibrillation: population-based evidence from a large-scale prospective cohort study","volume":"13","author":"Li","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1461613","DOI":"10.3389\/fendo.2025.1461613","article-title":"Inverse association between remnant cholesterol and risks of atrial fibrillation among patients with type 2 diabetes","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/jcm14092919","article-title":"Beyond pulmonary vein reconnection: exploring the dynamic pathophysiology of atrial fibrillation recurrence after catheter ablation","volume":"14","author":"Vlachakis","year":"2025","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.hrthm.2024.08.062","article-title":"Lesion delivery and scar formation in catheter ablation for atrial fibrillation: the DECAAF II trial","volume":"22","author":"Akoum","year":"2025","journal-title":"Heart Rhythm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cells15010036","article-title":"Molecular mechanisms of atrial fibrillation recurrence after successful catheter ablation","volume":"15","author":"Sanusi","year":"2026","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.08.026","article-title":"Lipid levels, atrial fibrillation and the impact of age: results from the LIPIDOGRAM2015 study","volume":"312","author":"Harrison","year":"2020","journal-title":"Atherosclerosis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e001211","DOI":"10.1161\/JAHA.114.001211","article-title":"Blood lipids and the incidence of atrial fibrillation: the multi-ethnic study of atherosclerosis and the framingham heart study","volume":"3","author":"Alonso","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jacl.2022.04.003","article-title":"Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: a report from the kuopio ischaemic heart disease risk factor study (KIHD)","volume":"16","author":"Tajik","year":"2022","journal-title":"J Clin Lipidol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1004044","DOI":"10.1371\/journal.pmed.1004044","article-title":"Lipid levels in midlife and risk of atrial fibrillation over 3 decades-experience from the Swedish AMORIS cohort: a cohort study","volume":"19","author":"Ding","year":"2022","journal-title":"PLoS Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"932262","DOI":"10.3389\/fcvm.2022.932262","article-title":"Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation","volume":"9","author":"Conte","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.labinv.2022.100004","article-title":"Adipose triglyceride lipase deficiency aggravates angiotensin II-induced atrial fibrillation by reducing peroxisome proliferator-activated receptor \u03b1 activation in mice","volume":"103","author":"Han","year":"2023","journal-title":"Lab Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jelectrocard.2020.12.008","article-title":"Paradoxical association between atrial fibrillation\/flutter and high cholesterol over age 75 years: the Kuakini Honolulu heart program and Honolulu-Asia aging study","volume":"65","author":"Anzai","year":"2021","journal-title":"J Electrocardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12944-026-02941-2","article-title":"Joint associations of grip strength, lipid levels, and lipid-related genetic risk with atrial fibrillation","volume":"25","author":"Zhang","year":"2026","journal-title":"Lipids Health Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.11.021","article-title":"Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation","author":"Xu","year":"2025","journal-title":"Heart Rhythm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e14119","DOI":"10.1111\/eci.14119","article-title":"Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation results from a population-based study","volume":"54","author":"Tada","year":"2024","journal-title":"Eur J Clin Investig"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.numecd.2021.02.011","article-title":"Causal effects of plasma lipids on the risk of atrial fibrillation: a multivariable Mendelian randomization study","volume":"31","author":"Jiang","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/nu14010181","article-title":"The relationship between blood lipids and risk of atrial fibrillation: univariable and multivariable Mendelian randomization analysis","volume":"14","author":"Yang","year":"2022","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000538551","article-title":"Drug target Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and atrial fibrillation","volume":"149","author":"Li","year":"2024","journal-title":"Cardiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2188\/jea.JE20240428","article-title":"Extremely elevated high-density lipoprotein cholesterol and the risk of atrial fibrillation: the suita study","volume":"35","author":"Arafa","year":"2025","journal-title":"J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.hrthm.2023.11.024","article-title":"Oxidized high-density lipoprotein associates with atrial fibrillation","volume":"21","author":"Pagonas","year":"2024","journal-title":"Heart Rhythm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1038\/s41598-021-82998-4","article-title":"The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation","volume":"11","author":"Minami-Takano","year":"2021","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00380-021-01908-w","article-title":"Anti-inflammatory HDL effects are impaired in atrial fibrillation","volume":"37","author":"Holzwirth","year":"2022","journal-title":"Heart Vessels"},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00395-019-0735-0","article-title":"Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number","volume":"114","author":"Trieb","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.hrthm.2024.10.030","article-title":"Remnant cholesterol and new-onset atrial fibrillation: the atherosclerosis risk in communities study","volume":"22","author":"Ouyang","year":"2025","journal-title":"Heart Rhythm"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.hrthm.2024.11.019","article-title":"The association between remnant cholesterol levels and the risk of atrial fibrillation: a deeper dive into a dramatic reversal in findings","volume":"22","author":"DeSantis","year":"2025","journal-title":"Heart Rhythm"},{"key":"B33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12916-025-04329-y","article-title":"The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in east asians","volume":"23","author":"Lin","year":"2025","journal-title":"BMC Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12933-023-01927-z","article-title":"Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a Mendelian randomization analysis","volume":"22","author":"Guan","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"27038","DOI":"10.1038\/s41598-024-78610-0","article-title":"Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample Mendelian randomization study","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12872-023-03283-y","article-title":"Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case-control study","volume":"23","author":"Zhong","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.34172\/jcvtr.2020.23","article-title":"Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects","volume":"12","author":"\u00c7\u0131nar","year":"2020","journal-title":"J Cardiovasc Thorac Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e936425","DOI":"10.12659\/MSM.936425","article-title":"Case-Control study to investigate the association between Serum apolipoprotein B\/A1 ratio and atrial fibrillation by sex in 920 patients from China","volume":"28","author":"Zhong","year":"2022","journal-title":"Med Sci Monit"},{"key":"B39","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.1038\/s41598-022-13773-2","article-title":"Association between serum apolipoprotein B and atrial fibrillation: a case-control study","volume":"12","author":"Zhong","year":"2022","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12944-026-02905-6","article-title":"A population-based study of the sex-specific associations between apolipoprotein B and incidence of atrial fibrillation","volume":"25","author":"Wei","year":"2026","journal-title":"Lipids Health Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/joim.13393","article-title":"High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women","volume":"291","author":"Sveen","year":"2022","journal-title":"J Intern Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jacc.2022.02.018","article-title":"Elevated lipoprotein(a) and risk of atrial fibrillation: an observational and Mendelian randomization study","volume":"79","author":"Mohammadi-Shemirani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16924","DOI":"10.20452\/pamw.16924","article-title":"The role of lipoprotein(a) in atrial fibrillation: a systematic review","volume":"135","author":"Procyk","year":"2025","journal-title":"Pol Arch Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7150\/ijms.102301","article-title":"Lipoprotein(a) and atrial fibrillation: mechanistic insights and therapeutic approaches","volume":"22","author":"Zhang","year":"2025","journal-title":"Int J Med Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1016\/j.hrthm.2025.08.001","article-title":"Lipoprotein(a) elevation independently associates with incident atrial fibrillation irrespective of inflammatory status","volume":"22","author":"Li","year":"2025","journal-title":"Heart Rhythm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/eurjpc\/zwaf063","article-title":"Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study","volume":"32","author":"Awad","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e007372","DOI":"10.1161\/JAHA.117.007372","article-title":"Associations of lipoprotein(a) levels with incident atrial fibrillation and ischemic stroke: the ARIC (atherosclerosis risk in communities) study","volume":"6","author":"Aronis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e008401","DOI":"10.1161\/CIRCEP.120.008401","article-title":"Lp(a) (lipoprotein [a]) and risk for incident atrial fibrillation: multi-ethnic study of atherosclerosis","volume":"13","author":"Garg","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"102343","DOI":"10.1016\/j.jacadv.2025.102343","article-title":"Association of lipoprotein(a) with atrial fibrillation in the framingham heart study","volume":"4","author":"Hategeka","year":"2025","journal-title":"JACC Advances"},{"key":"B50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12944-022-01728-5","article-title":"Low lipoprotein(a) concentration is associated with atrial fibrillation: a large retrospective cohort study","volume":"21","author":"Tao","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/clc.24086","article-title":"The association between lipoprotein(a) and atrial fibrillation: a systemic review and meta-analysis","volume":"46","author":"Yang","year":"2023","journal-title":"Clin Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-023-01990-1","article-title":"Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA(2)DS(2)-VASc scores: a cross-sectional study","volume":"23","author":"Kamili","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101942","DOI":"10.1016\/j.ijcha.2026.101942","article-title":"Integrating left atrial appendage morphology and lipoprotein(a) improves thrombus risk stratification in atrial fibrillation: a retrospective cohort study","volume":"64","author":"Song","year":"2026","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jacep.2021.01.011","article-title":"The blinding period following ablation therapy for atrial fibrillation: proarrhythmic and antiarrhythmic pathophysiological mechanisms","volume":"7","author":"Gottlieb","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-025-02985-1","article-title":"Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation","volume":"25","author":"Meulendijks","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000540289","article-title":"Combination of epicardial adipose tissue and left atrial low-voltage areas predicting atrial fibrillation recurrence after radiofrequency ablation","volume":"150","author":"Qiu","year":"2024","journal-title":"Cardiology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10840-019-00543-w","article-title":"Blood lipid levels and recurrence of atrial fibrillation after radiofrequency catheter ablation: a prospective study","volume":"57","author":"Shang","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e24276","DOI":"10.1002\/clc.24276","article-title":"Plasma triglyceride is associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation: a retrospective study","volume":"47","author":"Gu","year":"2024","journal-title":"Clin Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12872-022-02657-y","article-title":"The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/pace.70059","article-title":"The triglyceride-glucose Index predicts early recurrence of atrial fibrillation after ablation in non-diabetic patients","volume":"48","author":"Sang","year":"2025","journal-title":"Pacing Clin Electrophysiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-024-02158-6","article-title":"Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s40001-025-03093-2","article-title":"Insulin resistance, left atrial anatomical remodeling, and recurrence in patients with atrial fibrillation undergoing radiofrequency ablation","volume":"30","author":"Qin","year":"2025","journal-title":"Eur J Med Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-024-02219-w","article-title":"Association between triglyceride-glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation","volume":"23","author":"Jia","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"200","DOI":"10.26599\/1671-5411.2024.02.005","article-title":"Association between the cumulative triglyceride-glucose index and the recurrence of atrial fibrillation after radiofrequency catheter ablation","volume":"21","author":"Yan","year":"2024","journal-title":"J Geriatr Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1016\/j.hrthm.2025.04.050","article-title":"Association between surrogate insulin resistance markers and postablation atrial fibrillation recurrence: a systematic review and meta-analysis","volume":"22","author":"Ghoshouni","year":"2025","journal-title":"Heart Rhythm"},{"key":"B66","doi-asserted-by":"publisher","first-page":"28434","DOI":"10.1038\/s41598-024-79836-8","article-title":"L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: a prospective cohort study","volume":"14","author":"Zou","year":"2024","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e938288","DOI":"10.12659\/MSM.938288","article-title":"Association between Pre-radiofrequency catheter ablation Serum lipid levels and recurrence of atrial fibrillation in 412 patients in Beijing, China: a single-center study","volume":"29","author":"Li","year":"2023","journal-title":"Med Sci Monit"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e12787","DOI":"10.1111\/anec.12787","article-title":"Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation","volume":"25","author":"Li","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/europace\/euu291","article-title":"The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation","volume":"17","author":"Canpolat","year":"2015","journal-title":"Europace"},{"key":"B70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12872-020-01670-3","article-title":"The preablation monocyte\/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"B71","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s13019-024-03136-5","article-title":"The predictive value of monocyte count to high-density lipoprotein cholesterol ratio combined with left atrial diameter for post-radiofrequency ablation recurrence of paroxysmal atrial fibrillation in patients","volume":"19","author":"Lei","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e081808","DOI":"10.1136\/bmjopen-2023-081808","article-title":"Significance of the APPLE score and the monocyte-HDL cholesterol ratio in predicting late recurrence of atrial fibrillation following catheter ablation based on a retrospective study","volume":"14","author":"Song","year":"2024","journal-title":"BMJ open"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7854","DOI":"10.3390\/jcm13247854","article-title":"The uric acid-to-high-density lipoprotein cholesterol ratio: a new biomarker for predicting arrhythmia recurrence after atrial fibrillation ablation","volume":"13","author":"Dervis","year":"2024","journal-title":"J Clin Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1142\/S0219519425400986","article-title":"Serum uric acid to high-density lipoprotein cholesterol ratio: a novel biomarker for predicting atrial fibrillation recurrence after cryoablation","volume":"25","author":"Yang","year":"2025","journal-title":"J Mech Med Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1258125","DOI":"10.3389\/fcvm.2023.1258125","article-title":"Predictive value of remnant-like particle cholesterol in the prediction of long-term AF recurrence after radiofrequency catheter ablation","volume":"10","author":"Wu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0315905","DOI":"10.1371\/journal.pone.0315905","article-title":"Apolipoprotein and sphingolipid measurements: can be used in the clinical practice of atrial fibrillation diagnosing and evaluating the cryoablation effectiveness?","volume":"20","author":"Bielawiec","year":"2025","journal-title":"PLoS One"},{"key":"B77","volume-title":"Association between the apolipoprotein B\/apolipoprotein A1 ratio and recurrence after radiofrequency catheter ablation for atrial fibrillation","author":"Yang","year":"2024"},{"key":"B78","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2459\/JCM.0000000000001787","article-title":"Lipoprotein(a) and risk of recurrent atrial fibrillation after pulsed field ablation","volume":"26","author":"Zuin","year":"2025","journal-title":"J Cardiovasc Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40001-025-02286-z","article-title":"Multimodal data-based longitudinal prognostic model for predicting atrial fibrillation recurrence after catheter ablation in patients with patent foramen ovale and paroxysmal atrial fibrillation","volume":"30","author":"Duan","year":"2025","journal-title":"Eur J Med Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e33907","DOI":"10.1097\/MD.0000000000033907","article-title":"Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke","volume":"102","author":"Hu","year":"2023","journal-title":"Medicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.amjmed.2022.02.016","article-title":"Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from the ODYSSEY OUTCOMES trial","volume":"135","author":"Lopes","year":"2022","journal-title":"Am J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2021.1489","article-title":"Effect of marine Omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial","volume":"325","author":"Albert","year":"2021","journal-title":"Jama"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose Omega-3 fatty acids vs corn oil on Major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"Jama"},{"key":"B84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.123.065520","article-title":"Randomized trial for evaluation in secondary prevention efficacy of combination therapy-statin and eicosapentaenoic acid (RESPECT-EPA)","volume":"150","author":"Miyauchi","year":"2024","journal-title":"Circulation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.121.055654","article-title":"Effect of long-term marine \u0277-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis","volume":"144","author":"Gencer","year":"2021","journal-title":"Circulation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jacc.2023.05.024","article-title":"Omega-3 fatty acid biomarkers and incident atrial fibrillation","volume":"82","author":"Qian","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes Mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/ehjcvp\/pvaf040","article-title":"Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials","volume":"11","author":"Fedele","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B91","doi-asserted-by":"publisher","first-page":"zwaf257","DOI":"10.1093\/eurjpc\/zwaf257","article-title":"Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials","author":"Cesaro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s11606-023-08589-3","article-title":"Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study","volume":"39","author":"Xu","year":"2024","journal-title":"J Gen Intern Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e009115","DOI":"10.1161\/CIRCEP.120.009115","article-title":"Metformin is associated with a lower risk of atrial fibrillation and ventricular arrhythmias compared with sulfonylureas: an observational study","volume":"14","author":"Ostropolets","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jacc.2016.09.940","article-title":"Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects","volume":"68","author":"Jamaly","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1111\/jce.16786","article-title":"Atrial fibrillation recurrence reduction: what treatments work best postablation? A network meta-analysis","volume":"36","author":"Jaroonpipatkul","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamacardio.2025.4007","article-title":"Aggressive risk factor reduction study for atrial fibrillation implications for ablation outcomes: the ARREST-AF randomized clinical trial","volume":"10","author":"Pathak","year":"2025","journal-title":"JAMA cardiology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e031269","DOI":"10.1161\/JAHA.123.031269","article-title":"Impact of sodium-glucose cotransporter 2 inhibitor on recurrence after catheter ablation for atrial fibrillation in patients with diabetes: a propensity-score matching study and meta-analysis","volume":"12","author":"Zhao","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.125.077447","article-title":"Dapagliflozin to reduce early recurrence after catheter ablation for atrial fibrillation: the DARE-AF randomized clinical trial","volume":"153","author":"Jiang","year":"2026","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10840-026-02297-8","article-title":"Comparing GLP-1 agonists versus other weight loss interventions on risk of atrial fibrillation recurrence after catheter ablation: a meta-analysis","volume":"69","author":"Li","year":"2026","journal-title":"J Interv Card Electrophysiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"euag018","DOI":"10.1093\/europace\/euag018","article-title":"Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation","volume":"28","author":"Ciconte","year":"2026","journal-title":"Europace"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2026.03.026","article-title":"The liraglutide effects in atrial fibrillation (LEAF) study","author":"Goldberger","year":"2026","journal-title":"JACC Clin Electrophysiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/jce.14954","article-title":"Effect of metformin on outcomes of catheter ablation for atrial fibrillation","volume":"32","author":"Deshmukh","year":"2021","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1909014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:58:10Z","timestamp":1788335890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1909014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":103,"alternative-id":["10.3389\/fcvm.2026.1909014"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1909014","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"1909014"}}